JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 2, 2004; DOI: 10.1124/jpet.103.064873


0022-3565/04/3102-761-773$20.00
JPET 310:761-773, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.064873v1
jpet.103.064873v2
310/2/761    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiong, W.
Right arrow Articles by Howlett, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiong, W.
Right arrow Articles by Howlett, S. E.

CARDIOVASCULAR

Diminished Inotropic Response to Amrinone in Ventricular Myocytes from Myopathic Hamsters Is Linked to Depression of High-Gain Ca2+-Induced Ca2+ Release

Wei Xiong, Gregory R. Ferrier, and Susan E. Howlett

Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada

This study investigates whether amrinone (100-1000 µM), a phosphodiesterase-III inhibitor, can alleviate depression of contractions in ventricular myocytes from prefailure cardiomyopathic (CM) hamsters (80-100 days). Cell shortening and ion currents were measured in voltage-clamped cells at 37°C. Normal myocytes exhibited low-gain Ca2+-induced Ca2+ release (CICR) initiated by test steps from -40 mV and high-gain CICR initiated from more negative potentials. In normal myocytes, amrinone selectively increased contractions initiated by high-gain CICR (fractional shortening increased from 3.6 ± 0.5% to 5.3 ± 0.6%, 300 µM amrinone) but had no effect on low-gain CICR. Amrinone decreased L-type Ca2+ current (ICa-L; -5.5 ± 0.8 to -3.7 ± 0.5 picoAmp/picoFarad, 300 µM amrinone). In contrast, in CM myocytes, high-gain CICR was virtually absent, and amrinone had no inotropic effect. Amrinone inhibited ICa-L less in CM than normal myocytes. Sarcoplasmic reticulum (SR) Ca2+ stores, assessed by caffeine, were significantly increased by amrinone in normal but not CM myocytes. Thus, the positive inotropic effect of amrinone in normal hamster myocytes was mediated by selective enhancement of high-gain CICR. This effect was not mediated by stimulation of ICa-L because ICa-L is inhibited by this drug in hamster. High-gain CICR, which is depressed in CM myocytes, cannot be restored by amrinone. However, minimal stimulation of adenylyl cyclase with forskolin restored the positive inotropic effect of amrinone in CM cells. This positive inotropic effect of amrinone may reflect increased SR Ca2+ stores because increased stores accompanied the positive inotropic effect in normal myocytes but were absent in CM myocytes.


Received December 23, 2003; accepted March 30, 2004.

Address correspondence to: Dr. Susan E. Howlett, Department of Pharmacology, Sir Charles Tupper Medical Building, Dalhousie University, Halifax, NS, Canada B3H 4H7. E-mail: Susan.Howlett{at}dal.ca







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.